We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > metastatic urothelial carcinoma

News List

BAVENCIO Significantly Improved Overall Survival in Patients With Locally Advanced or Metastatic Urothelial Carcinoma prnasia
January 06, 2020
The results of the study will be submitted for presentation at an upcoming medical congress and shared with the US Food and Drug Administration (FDA) and other health authorities.
EC Approves Opdivo for Previously Treated Locally Advanced Unresectable or Metastatic Urothelial Car americanpharmaceuticalreview
June 07, 2017
Bristol-Myers Squibb announced the European Commission (EC) has approved Opdivo (nivolumab) for the treatment of locally advanced unresectable...
FDA accepts the biologics license application for Avelumab for the treatment of metastatic urothelia pharmaasia
March 14, 2017
Merck and Pfizer announced that the US Food and Drug Administration has accepted for Priority Review the Biologics License Application for avelumab